Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain

BACKGROUND: In a recent study, autoantibodies neutralizing type I interferons (IFNs) were present in at least 10% of cases of critical COVID-19 pneumonia. These autoantibodies neutralized most type I IFNs but rarely IFN-beta. OBJECTIVES: We aimed to define the prevalence of autoantibodies neutralizi...

Descripción completa

Detalles Bibliográficos
Autores principales: Troya, Jesús, Bastard, Paul, Planas-Serra, Laura, Ryan, Pablo, Ruiz, Montse, de Carranza, María, Torres, Juan, Martínez, Amalia, Abel, Laurent, Casanova, Jean-Laurent, Pujol, Aurora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043439/
https://www.ncbi.nlm.nih.gov/pubmed/33851338
http://dx.doi.org/10.1007/s10875-021-01036-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043439/
https://www.ncbi.nlm.nih.gov/pubmed/33851338
http://dx.doi.org/10.1007/s10875-021-01036-0

Ejemplares similares